Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial by McCarthy, Matthew W, Naggie, Susanna, Boulware, David R, Lindsell, Christopher J, Stewart, Thomas G, Felker, G. Michael, Jayaweera, Dushyantha, Sulkowski, Mark, Gentile, Nina, Bramante, Carolyn, Singh, Upinder, Dolor, Rowena J, Ruiz-Unger, Juan, Wilson, Sybil, DeLong, Allison, Remaly, April, Wilder, Rhonda, Collins, Sean, Dunsmore, Sarah E, Adam, Stacey J, Thicklin, Florence, Hanna, George, Ginde, Adit A, Castro, Mario, McTigue, Kathleen, Shenkman, Elizabeth, Hernandez, Adrian F

Get full text

Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis by Gottlieb, Alice B, Kang, Sewon, Linden, Kenneth G, Lebwohl, Mark, Menter, Alan, Abdulghani, Ahsan A, Goldfarb, Michael, Chieffo, Nicole, Totoritis, Mark C

Get full text

Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody by Gottlieb, Alice B., Lebwohl, Mark, Totoritis, Mark C., Abdulghani, Ahsan A., Shuey, Steve R., Romano, Patricia, Chaudhari, Umesh, Allen, Roberta S., Lizambri, Richard G.

Get full text

Studies of the effects of topical vitamin C, a copper binding cream, and melatonin cream as compared with tretinoin on the ultrastructure of normal skin by Abdulghani, Ahsan A., Shirin, Sophie, Morales-Tapia, Elvira, Sherr, Amelia, Solodkina, Galina, Robertson, Mikal, Gottlieb, Alice B.

Get full text

Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris by Gottlieb, Alice B., Masuda, Salman, Ramamurthi, Rallapalli, Abdulghani, Ahsan, Romano, Pat, Chaudhari, Umesh, Dooley, Lisa T., Fasanmade, Adedigbo A., Wagner, Carrie L.

Get full text